ACADIA PHARMACEUTICALS INC 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jan 3, 2014
Insider Transaction Report
Form 4
Aasen Thomas H
Exec. VP, CFO & CBO
Transactions
- Gift
Common Stock
2014-01-02−30,000→ 31,348 total - Exercise/Conversion
Common Stock
2014-01-02$1.55/sh+22,000$34,100→ 61,348 total - Sale
Common Stock
2014-01-02$24.88/sh−30,000$746,334→ 0 total(indirect: By Trust) - Exercise/Conversion
Stock Option (right to buy)
2014-01-02−22,000→ 90,471 totalExercise: $1.55Exp: 2020-03-11→ Common Stock (22,000 underlying)
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in 2012.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $24.50 to $25.01 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range.
- [F3]25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.